Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma  

作　　者：Pete A.Williams Robert J.Casson 

机构地区：[1]Department of Clinical Neuroscience,Division of Eye and Vision,St.Erik Eye Hospital,Karolinska Institutet,Stockholm,Sweden [2]Ophthalmic Research Laboratories,Discipline of Ophthalmology and Visual Sciences,University of Adelaide,Adelaide,Australia

出　　处：《Neural Regeneration Research》2024年第8期1637-1638,共2页中国神经再生研究（英文版）

基　　金：supported by Karolinska Institutet in the form of a Board of Research Faculty Funded Career Position;by St.Erik Eye Hospital philanthropic donations;Vetenskapsr?det2022-00799(to PAW);Alcon Research Institute Young Investigator。

摘　　要：Vision is arguably our most valued sense,yet approximately 340 million people globally suffer blindness or moderate visual impairment,highlighting the need to further develop and advance treatments for ophthalmic diseases.Glaucoma refers to a group of ocular disorders united by a clinically characteristic optic neuropathy with associated retinal ganglion cell loss.

关 键 词：METABOLISM GLAUCOMA globally 

分 类 号：R775[医药卫生—眼科]